Sat.Apr 17, 2021

article thumbnail

Heart patients advised to move more to avoid heart attacks and strokes

Scienmag

Sophia Antipolis – 17 April 2021: Elevated blood pressure, high cholesterol and diabetes increase the risk of heart disease. But a large study today reveals that in people with these conditions, increasing activity levels is associated with a reduced likelihood of heart events and mortality. The research is presented at ESC Preventive Cardiology 2021, an […].

article thumbnail

Rollingwood TX Dental Veneers For Chipped Or Cracked Teeth Services Launched

BioTech 365

Rollingwood TX Dental Veneers For Chipped Or Cracked Teeth Services Launched Rollingwood TX Dental Veneers For Chipped Or Cracked Teeth Services Launched Westlake Hills Dental Arts is now providing an updated range of dental veneer treatments for patients in Rollingwood, … Continue reading →

52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Accelerate Development of KRAS and TRAILR2 Compounds in Lung Cancer

The Pharma Data

Boehringer Ingelheim and The University of Texas MD Anderson Cancer Center today announced the extension and expansion of their joint Virtual Research and Development Center (VRDC) to explore new molecules from Boehringer Ingelheim’s KRAS (Kirsten rat sarcoma) and TRAILR2 (TNF-related apoptosis-inducing ligand receptor 2) portfolios for the potential treatment of lung cancer, particularly non-small cell lung cancer.

article thumbnail

Broomfield CO Dental Hygienist – X-Ray Check-Up Exam/Cleaning Services Expanded

BioTech 365

Broomfield CO Dental Hygienist – X-Ray Check-Up Exam/Cleaning Services Expanded Broomfield CO Dental Hygienist – X-Ray Check-Up Exam/Cleaning Services Expanded SmileLogic is updating its dental hygiene services to include digital radiography (digital X-rays) as part of its innovative dental hygiene … Continue reading →

52
article thumbnail

European Clinical Supply Planning: Balancing Cost, Flexibility and Time

article thumbnail

Boehringer Ingelheim adds blue internal teat sealant to its dairy mastitis portfolio

The Pharma Data

Boehringer Ingelheim continues to stay at the forefront of innovation and provide producers with the right tools for disease prevention. The Company’s Ubroseal ® Blue brings confidence of best practice when it comes to sealant administration and removal. Boehringer Ingelheim, a global leader in animal health, announces that it has updated its Ubroseal ® internal teat sealant to Ubroseal ® Blue earlier this year.

Sales 52
article thumbnail

GC Pharma Lights Up to Celebrate ‘World Hemophilia Day’

BioTech 365

GC Pharma Lights Up to Celebrate ‘World Hemophilia Day’ GC Pharma Lights Up to Celebrate ‘World Hemophilia Day’ The Company features this year’s slogan image on media façade YONGIN, South Korea–(BUSINESS WIRE)–GC Pharma (formerly known as Green Cross Corporation), a … Continue reading →

52

More Trending

article thumbnail

Drug Patent Expirations for the Week of April 18, 2021

Drug Patent Watch

ZYDELIG (idelalisib) Gilead sciences inc Patent: 6,800,620 Expiration: Apr 24, 2021 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com…. The post Drug Patent Expirations for the Week of April 18, 2021 appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 40
article thumbnail

MS PORTFOLIO DEMONSTRATE POSITIVE IMPACT OF TREATMENT ON PEOPLE LIVING WITH RELAPSING MULTIPLE SCLEROSIS

The Pharma Data

New findings from MS PATHS show that treatment with TYSABRI ® (natalizumab) can lead to meaningful improvements in mental and social health compared to Ocrevus ® (ocrelizumab). Real-world data from VUMERITY ® (diroximel fumarate) reinforce the treatment’s positive gastrointestinal tolerability profile. Biogen advances leading research to help inform future patient management including new information on the clinical profile of extended interval dosing with natalizumab.

article thumbnail

VASCEPA® (Icosapent Ethyl) Reported to Impact Vulnerable Coronary Plaque Features in New Analyses of EVAPORATE Study Presented as Late-Breaking Science at ESC Preventive Cardiology 2021

BioTech 365

VASCEPA® (Icosapent Ethyl) Reported to Impact Vulnerable Coronary Plaque Features in New Analyses of EVAPORATE Study Presented as Late-Breaking Science at ESC Preventive Cardiology 2021 VASCEPA® (Icosapent Ethyl) Reported to Impact Vulnerable Coronary Plaque Features in New Analyses of EVAPORATE … Continue reading →

article thumbnail

Which pharmaceutical companies have the most powder dosed drugs?

Drug Patent Watch

This chart shows the pharmaceutical companies with the most powder dosed drugs. For a different perspective, see the most popular dosage types. The companies with the most powder dosed drugs…. The post Which pharmaceutical companies have the most powder dosed drugs? appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 98
article thumbnail

The New Age of Decentralized Clinical Trials

White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations

article thumbnail

Avadel Presents New Data from its Pivotal REST-ON Phase 3 Trial of FT218, once-nightly sodium oxybate, at the 2021 American Academy of Neurology Annual Meeting

BioTech 365

Avadel Presents New Data from its Pivotal REST-ON Phase 3 Trial of FT218, once-nightly sodium oxybate, at the 2021 American Academy of Neurology Annual Meeting Avadel Presents New Data from its Pivotal REST-ON Phase 3 Trial of FT218, once-nightly sodium … Continue reading →

Trials 40
article thumbnail

New Analyses of AJOVY® (fremanezumab-vfrm) Injection and AUSTEDO® (deutetrabenazine) Tablets

The Pharma Data

Teva Pharmaceuticals USA, Inc., a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), today announced 19 presentations examining clinical and real-world data for AJOVY ® (fremanezumab-vfrm) injection and AUSTEDO ® (deutetrabenazine) tablets will be presented at the upcoming 2021 American Academy of Neurology (AAN) Virtual Annual Meeting, taking place April 17-22.

article thumbnail

Elucid Presents Results of the EVAPORATE Study at ESC Preventive Cardiology 2021 Late Breakers

BioTech 365

Elucid Presents Results of the EVAPORATE Study at ESC Preventive Cardiology 2021 Late Breakers Elucid Presents Results of the EVAPORATE Study at ESC Preventive Cardiology 2021 Late Breakers Elucid Software Quantifies Plaque Morphology to Enable Better Assessment of IPE Treatment … Continue reading →

article thumbnail

Autobahn Therapeutics Presents Preclinical, Proof of Concept Data for ABX-002 for the Treatment of Adrenomyeloneuropathy

BioTech 365

Autobahn Therapeutics Presents Preclinical, Proof of Concept Data for ABX-002 for the Treatment of Adrenomyeloneuropathy Autobahn Therapeutics Presents Preclinical, Proof of Concept Data for ABX-002 for the Treatment of Adrenomyeloneuropathy First Data Presented Showcasing Autobahn’s Novel FAAH-Mediated Prodrug Approach for … Continue reading →

52
article thumbnail

Unlocking Excellence: How Catalent Is Transforming Japan’s Clinical Research

Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud